eISSN: 2299-551X
ISSN: 0011-4553
Journal of Stomatology
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2021
vol. 74
 
Share:
Share:
abstract:
Original paper

Estimation of salivary matrix metalloproteinase-9 in oral leukoplakia, oral submucous fibrosis, and healthy individuals: a comparative observational study

Akshaya Thiruvalluvan
1
,
Jagat R.C. Reddy
1
,
Vandana Sekizhar
1
,
Veni Subramanyam
2
,
Sivasankari T.
1
,
Varsha V.
2

  1. Department of Oral Medicine and Radiology, Indira Gandhi Institute of Dental Sciences, Sri Balaji Vidyapeeth (Deemed to be university), Puducherry, India
  2. Central Inter-Disciplinary Research Facility (CIDRF), Sri Balaji Vidyapeeth, Pillaiyarkuppam, Puducherry, India
J Stoma 2021; 74, 4: 221-226
Online publish date: 2021/12/19
View full text Get citation
 
PlumX metrics:
Introduction
Salivary matrix metalloproteinase-9 (MMP-9) is an established diagnostic biomarker for detection and prognosis of oral cancer.

Objectives: The current study aimed to estimate salivary MMP-9 in oral leukoplakia and oral submucous fibrosis (OSMF), which are considered as oral potentially malignant disorders (OPMDs).

Material and methods
A comparative observational study of 60 subjects was conducted, including 20 patients diagnosed with OSMF (group A, n = 20), 20 diagnosed with oral leukoplakia (group B, n = 20), and 20 as healthy controls (group C, n = 20) according to standard criteria. Unstimulated salivary samples were collected for evaluation of MMP-9 by enzyme-linked immunosorbent assay (ELISA). One-way analysis of variance (ANOVA) test was applied for comparison of groups. Bonferroni-adjusted one-way ANOVA test was performed for intra-group comparison.

Results
Descriptive statistics of the data revealed that mean age of study participants in group A, group B, and group C were 50.30 ± 9.96 years, 46.70 ± 12.59 years, and 33.30 ± 4.70 years, respectively. Mean salivary MMP-9 level in OSMF, oral leukoplakia, and control group were 9.42 ng/ml, 10.59 ng/ml, and 2.96 ng/ml, respectively, with a p-value < 0.001 between OSMF and oral leukoplakia when compared with controls.

Conclusions
A significant difference was noted in salivary MMP-9 levels among patients with OPMD’s compared to controls. A slightly higher value of MMP-9 was observed in oral leukoplakia. Estimation of salivary MMP-9 level is a non-invasive and a reliable biomarker in diagnosis of OPMD’s and in accessing their malignant transformation.

keywords:

matrix metalloproteinase-9, oral potentially malignant disorders, oral leukoplakia, oral submucous fibrosis, oral squamous cell carcinoma

 
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.